Table 3.

Baseline characteristics and clinical features of the enrolled participants.

Participant (P)		Age (years)	Sex	Race	Ethnicity	Current pump use	Previous CGMa use
Intervention (i) group
	P1-i	17	Male	White	Non-Hispanic	Yes	N/Ab
	P2-i	16	Female	Mixed	Non-Hispanic	No	N/A
	P3-i	17	Male	White	Non-Hispanic	No	N/A
	P4-i	15	Female	White	Non-Hispanic	Yes	N/A
	P5-i	20	Female	White	Hispanic	No	Brand: Dexcom Duration of use: 2 weeks Date: 2 years prior
	P6-i	16	Male	White	Non-Hispanic	No	Brand: Dexcom Duration: 12 weeks Date: 6 months prior
Enhanced standard care group or control (c) group
	P7-c	17	Female	White	Non-Hispanic	No	N/A
	P8-c	18	Male	Not reported	Hispanic	Yes	Brand: Medtronic Duration of use: 1 week Date: 4-5 years prior

^aCGM: continuous glucose monitor.

^bN/A: not applicable (they were naïve to CGM prior to study).